DUBLIN – Shares in Targovax ASA surged almost 40 percent to an all-time high Thursday on preliminary top-line data for its peptide-based therapeutic vaccine TG01.
To continue reading subscribe now to Latest News
Learn More about Latest News
Already a subscriber? Sign In or Buy now to activate your subscription
